Green Cross releases new antipyretic analgesic

Taksen 400 Ibuprofen, a new antipyretic analgesic developed by Green Cross Corp. / Courtesy of Green Cross Corp.

By Chung Hyun-chae

Green Cross Corp. has released a new antipyretic analgesic.

The medicine, Taksen 400 Ibuprofen, contains 400 milligrams of ibuprofen, an anti-inflammatory drug that is highly effective in reducing fever and has few gastrointestinal side effects.

A company spokesman said Taksen 400 Ibuprofen is effective in relieving fever caused by flu, back pain, menstrual pain, osteoarthritis and in postoperative analgesia.

“For those looking for a strong antipyretic effect, our new drug could be a better choice,” the spokesman said.

He said Taksen could also be a good choice for those looking for a stronger anti-inflammatory effect, because its main ingredient is naproxen, a nonsteroidal anti-inflammatory agent.

He said the new medicine is fast-acting because the liquid ingredients are in a soft capsule.

While ibuprofen is a type of nonsteroidal anti-inflammatory drug (NSAID) that is poorly water-soluble, the company made Taksen 400 Ibuprofen as a capsule by using a special method called Neosol. This is used to make soft capsule medicines that have poor water-soluble ingredients.